{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:34:38Z","timestamp":1760240078881,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1052580"],"award-info":[{"award-number":["GNT1052580"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["TropicalMed"],"abstract":"<jats:p>As the prevalence of lymphatic filariasis declines, it becomes crucial to adequately eliminate residual areas of endemicity and implement surveillance. To this end, serological assays have been developed, including the Bm14 Filariasis CELISA which recommends a specific optical density cut-off level. We used mixture modelling to assess positive cut-offs of Bm14 serology in children in Vanuatu using historical OD (Optical Density) ELISA values collected from a transmission assessment survey (2005) and a targeted child survey (2008). Mixture modelling is a statistical technique using probability distributions to identify subpopulations of positive and negative results (absolute cut-off value) and an 80% indeterminate range around the absolute cut-off (80% cut-off). Depending on programmatic choices, utilizing the lower 80% cut-off ensures the inclusion of all likely positives, however with the trade-off of lower specificity. For 2005, country-wide antibody prevalence estimates varied from 6.4% (previous cut-off) through 9.0% (absolute cut-off) to 17.3% (lower 80% cut-off). This corroborated historical evidence of hotspots in Pentecost Island in Penama province. For 2008, there were no differences in the prevalence rates using any of the thresholds. In conclusion, mixture modelling is a powerful tool that allows closer monitoring of residual transmission spots and these findings supported additional monitoring which was conducted in Penama in later years. Utilizing a statistical data-based cut-off, as opposed to a universal cut-off, may help guide program decisions that are better suited to the national program.<\/jats:p>","DOI":"10.3390\/tropicalmed4010045","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:21:59Z","timestamp":1552044119000},"page":"45","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Investigation of Mixture Modelling Algorithms as a Tool for Determining the Statistical Likelihood of Serological Exposure to Filariasis Utilizing Historical Data from the Lymphatic Filariasis Surveillance Program in Vanuatu"],"prefix":"10.3390","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2269-1132","authenticated-orcid":false,"given":"Hayley","family":"Joseph","sequence":"first","affiliation":[{"name":"The Walter and Eliza Hall Institute of Medical Research, Division of Population Health and Immunity, Melbourne, VIC 3052, Australia"},{"name":"Department of Medical Biology, The University of Melbourne, Melbourne, VIC 3052, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Sullivan","sequence":"additional","affiliation":[{"name":"Neglected Tropical Diseases Support Center, The Task Force for Global Health, Decatur, GA 30030, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Wood","sequence":"additional","affiliation":[{"name":"College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, QLD 4878, Australia"},{"name":"Great Barrier Reef Legacy, Cairns, QLD 4877, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wayne","family":"Melrose","sequence":"additional","affiliation":[{"name":"College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, QLD 4878, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fasihah","family":"Taleo","sequence":"additional","affiliation":[{"name":"Vector Borne Disease Unit, Ministry of Health, Port Vila, Vanuatu"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-3901","authenticated-orcid":false,"given":"Patricia","family":"Graves","sequence":"additional","affiliation":[{"name":"College of Public Health, Medical and Veterinary Sciences, James Cook University, Cairns, QLD 4878, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2018). Global programme to eliminate lymphatic filariasis: progress report, 2017. Wkly Epidemiol. Rec., 44, 589\u2013604."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pt.2016.09.009","article-title":"Can Lymphatic Filariasis Be Eliminated by 2020?","volume":"33","author":"Rebollo","year":"2017","journal-title":"Trends Parasitol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s41182-017-0075-4","article-title":"Overview of PacELF-the Pacific Programme for the Elimination of Lymphatic Filariasis","volume":"45","author":"Ichimori","year":"2017","journal-title":"Trop. Med. Health"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4269\/ajtmh.17-0371","article-title":"Use of Antibody Tools to Provide Serologic Evidence of Elimination of Lymphatic Filariasis in The Gambia","volume":"98","author":"Won","year":"2018","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2883-3-9","article-title":"Recombinant antigen-based antibody assays for the diagnosis and surveillance of lymphatic filariasis - a multicenter trial","volume":"3","author":"Lammie","year":"2004","journal-title":"Filaria J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"769","DOI":"10.4269\/ajtmh.2009.80.769","article-title":"Assessing transmission of lymphatic filariasis using parasitologic, serologic, and entomologic tools after mass drug administration in American Samoa","volume":"80","author":"Mladonicky","year":"2009","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1475-2883-3-3","article-title":"Spatial clustering of filarial transmission before and after a Mass Drug Administration in a setting of low infection prevalence","volume":"3","author":"Washington","year":"2004","journal-title":"Filaria J."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Weil, G.J., Kastens, W., Susapu, M., Laney, S.J., Williams, S.A., King, C.L., Kazura, J.W., and Bockarie, M.J. (2008). The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea. PLoS Negl. Trop. Dis., 2.","DOI":"10.1371\/journal.pntd.0000344"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1179\/2047773211Y.0000000008","article-title":"Epidemiological assessment of continuing transmission of lymphatic filariasis in Samoa","volume":"105","author":"Joseph","year":"2011","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-6851(99)00231-5","article-title":"The Wuchereria bancrofti orthologue of Brugia malayi SXP1 and the diagnosis of bancroftian filariasis","volume":"107","author":"Rao","year":"2000","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0166-6851(92)90176-K","article-title":"A cloned antigen for serological diagnosis of Wuchereria bancrofti microfilaremia with daytime blood samples","volume":"56","author":"Dissanayake","year":"1992","journal-title":"Mol. Biochem. Parasitol."},{"key":"ref_12","first-page":"12","article-title":"Exploratory study investigating factors influencing mass drug administration (MDA) compliance for lymphatic filariasis in Samoa","volume":"3","author":"Joseph","year":"2010","journal-title":"Samoa Med. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"492023","DOI":"10.1155\/2011\/492023","article-title":"Application of the Filariasis CELISA Antifilarial IgG(4) Antibody Assay in Surveillance in Lymphatic Filariasis Elimination Programmes in the South Pacific","volume":"2011","author":"Joseph","year":"2011","journal-title":"J. Trop. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.actatropica.2010.12.004","article-title":"First evidence of spatial clustering of lymphatic filariasis in an Aedes polynesiensis endemic area","volume":"120","author":"Joseph","year":"2011","journal-title":"Acta Trop."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"594687","DOI":"10.1155\/2010\/594687","article-title":"Applicability of the Filter Paper Technique for Detection of Antifilarial IgG(4) Antibodies Using the Bm14 Filariasis CELISA","volume":"2010","author":"Joseph","year":"2010","journal-title":"J. Parasitol. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Lau, C.L., Sheridan, S., Ryan, S., Roineau, M., Andreosso, A., Fuimaono, S., Tufa, J., and Graves, P.M. (2017). Detecting and confirming residual hotspots of lymphatic filariasis transmission in American Samoa 8 years after stopping mass drug administration. PLoS Negl. Trop. Dis., 11.","DOI":"10.1371\/journal.pntd.0005914"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Gass, K., Beau de Rochars, M.V., Boakye, D., Bradley, M., Fischer, P.U., Gyapong, J., Itoh, M., Ituaso-Conway, N., Joseph, H., and Kyelem, D. (2012). A multicenter evaluation of diagnostic tools to define endpoints for programs to eliminate bancroftian filariasis. PLoS Negl. Trop. Dis., 6.","DOI":"10.1371\/journal.pntd.0001479"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Masson, J., Douglass, J., Roineau, M., Aye, K.S., Htwe, K.M., Warner, J., and Graves, P.M. (2017). Concordance between Plasma and Filter Paper Sampling Techniques for the Lymphatic Filariasis Bm14 Antibody ELISA. Trop. Med. Infect. Dis., 2.","DOI":"10.3390\/tropicalmed2020006"},{"key":"ref_19","unstructured":"World Health Organization (2011). Lymphatic Filariasis: Monitoring and Epidemiological Assessment of Mass Drug Administration: A Manual for National Elimination Programmes, World Health Organization."},{"key":"ref_20","unstructured":"World Health Organization (2006). The PacELF Way: Towards Elimination of Lymphatic Filariasis 1999\u20132005, World Health Organization."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s41182-017-0047-8","article-title":"Impact of the Lymphatic Filariasis Control Program towards elimination of filariasis in Vanuatu, 1997\u20132006","volume":"45","author":"Allen","year":"2017","journal-title":"Trop. Med. Health"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s41182-017-0057-6","article-title":"Surveillance efforts after mass drug administration to validate elimination of lymphatic filariasis as a public health problem in Vanuatu","volume":"45","author":"Taleo","year":"2017","journal-title":"Trop. Med. Health"},{"key":"ref_23","first-page":"909","article-title":"Finite Mixture Modelling Using the Skew Normal Distribution","volume":"17","author":"Lin","year":"2007","journal-title":"Stat. Sin."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"McLachlan, G., and Peel, D. (2000). Finite Mixture Models, John Wiley & Sons.","DOI":"10.1002\/0471721182"},{"key":"ref_25","first-page":"3","article-title":"An Empirical Comparison of EM Initialization Methods and Model Choice Criteria for Mixtures of Skew-Normal Distributions","volume":"35","author":"Pereira","year":"2012","journal-title":"Rev. Colomb. Estad."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0167-9473(02)00177-9","article-title":"Choosing initial values for the EM algorithm for finite mixtures","volume":"41","author":"Karlis","year":"2003","journal-title":"J. Comput. Stat. Data Anal."},{"key":"ref_27","unstructured":"Thematic Mapping (2018, September 24). Simplified Country Borders. Available online: www.thematicmapping.org\/downloads\/world_borders.php."},{"key":"ref_28","unstructured":"(2019, January 05). ESRI Oceans Basemap. Available online: https:\/\/www.arcgis.com\/home\/item.html?id=6348e67824504fc9a62976434bf0d8d5."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Won, K.Y., Robinson, K., Hamlin, K.L., Tufa, J., Seespesara, M., Wiegand, R.E., Gass, K., Kubofcik, J., Nutman, T.B., and Lammie, P.J. (2018). Comparison of antigen and antibody responses in repeat lymphatic filariasis transmission assessment surveys in American Samoa. PLoS Negl. Trop. Dis., 12.","DOI":"10.1371\/journal.pntd.0006347"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1128\/jcm.19.2.200-203.1984","article-title":"Large-scale serological screening for cytomegalovirus antibodies in homosexual males by enzyme-linked immunosorbent assay","volume":"19","author":"Dylewski","year":"1984","journal-title":"J. Clin. Microbiol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Lau, C.L., Won, K.Y., Lammie, P.J., and Graves, P.M. (2016). Lymphatic Filariasis Elimination in American Samoa: Evaluation of Molecular Xenomonitoring as a Surveillance Tool in the Endgame. PLoS Negl. Trop. Dis., 10.","DOI":"10.1371\/journal.pntd.0005108"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lau, C.L., Won, K.Y., Becker, L., Soares Magalhaes, R.J., Fuimaono, S., Melrose, W., Lammie, P.J., and Graves, P.M. (2014). Seroprevalence and spatial epidemiology of Lymphatic Filariasis in American Samoa after successful mass drug administration. PLoS Negl. Trop. Dis., 8.","DOI":"10.1371\/journal.pntd.0003297"}],"container-title":["Tropical Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2414-6366\/4\/1\/45\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:37:19Z","timestamp":1760186239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2414-6366\/4\/1\/45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["tropicalmed4010045"],"URL":"https:\/\/doi.org\/10.3390\/tropicalmed4010045","relation":{},"ISSN":["2414-6366"],"issn-type":[{"type":"electronic","value":"2414-6366"}],"subject":[],"published":{"date-parts":[[2019,3,8]]}}}